ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: FR-PO765

Diffuse Proliferative Glomerulonephritis After Allogenic Hematopoietic Stem Cell Transplantation: A Rare Manifestation of Chronic Graft vs. Host Disease 

Session Information

Category: Transplantation

  • 2102 Transplantation: Clinical


  • Shen, Lei, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
  • Yang, Jing, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
  • Liu, Shaojun, Huashan Hospital Fudan University, Shanghai, Shanghai, China

Renal involvement is rare in chronic graft-versus-host disease (GVHD), of which membranous nephropathy (MN) and minimal change disease (MCD) were the most common renal pathological manifestations. In addition to glomerular diseases, thrombotic microangiopathy and tubulointerstitial diseases had also been detected in this entity.

Case Description

This paper presents a case report of a rare manifestation of chronic graft-versus-host disease (GVHD) in an 18-year-old male patient who underwent hematopoietic stem cell transplantation 3 years ago. This patient was clinically manifested as rapidly progressive glomerulonephritis with various autoantibodies detected in the serum and kidney, which was lupus-like manifestations. The renal pathology of this patient was immune complex-mediated diffuse proliferative glomerulonephritis with partial crescent formation, which was a rare manifestation of chronic GVHD. The patient initially received intensive immunosuppressive therapy and achieved partial remission.


Immune-complex mediated diffuse proliferative glomerulonephritis was a rare manifestation of chronic GVHD after HSCT, which response well to immunosuppressive therapy. Our findings suggest that a combination of methylprednisolone pulse and cyclophosphamide followed by mycophenolate mofetil and prednisone was effective in managing the condition. We emphasize the need to consider the possibility of different renal manifestations in GVHD and to give it adequate attention.